COMMUNIQUÉS West-GlobeNewswire

Innate Pharma annonce une publication dans “Cell Reports” sur une nouvelle génération d'immunothérapies ciblant la voie adénosine
23/05/2019
La production d'adénosine via les enzymes CD39 et CD73 participe à l’immunosuppression dans le microenvironnement tumoral. Les auteurs Perrot et al., ont produit deux anticorps, IPH5201 et IPH5301, ciblant [...]
Outcome of Annual General Meeting of May 22, 2019
23/05/2019
Marseille, France, May 23, 2019, 7:00 AM CEST Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces the results of the voting by shareholders at the Annual General Meeting (“AGM”) which took place on May 22, 2019 [...]
Résultats de l’Assemblée générale mixte du 22 mai 2019
23/05/2019
Marseille, le 23 mai 2019, 7h00 CEST Innate Pharma SA (Euronext Paris : FR0010331421 – IPH) annonce les résultats du vote des actionnaires à l’Assemblée générale mixte qui s’est tenue à Marseille le 22 mai 2019. Toutes [...]
Guardant Health Announces Pricing of Public Offering of Common Stock
23/05/2019
REDWOOD CITY, Calif., May 22, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq:GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast [...]
Arch Biopartners Closes Convertible Note Financing
22/05/2019
TORONTO, May 22, 2019 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced it has closed the non-brokered, unsecured convertible note (“Note”) financing it [...]
Dentsply Sirona Declares Quarterly Cash Dividend
22/05/2019
CHARLOTTE, N.C., May 22, 2019 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY), The Dental Solutions Company™, announced that its Board of Directors declared a quarterly cash dividend of $0. [...]
Iovance Biotherapeutics Announces Breakthrough Therapy Designation for LN-145 for Treatment of Advanced Cervical Cancer Patients Who Have Progressed on or After Chemotherapy
22/05/2019
SAN CARLOS, Calif., May 22, 2019 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]
Tonix Pharmaceuticals to Speak at the Second Chance Digital Impact Recipient Gala
22/05/2019
NEW YORK, May 22, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), today announced that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will speak [...]
Wave Life Sciences to Present at the Jefferies 2019 Healthcare Conference
22/05/2019
CAMBRIDGE, Mass., May 22, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating [...]
Kane Biotech Announces First Quarter 2019 Financial Results, Extension of Loan and Insider Funding
22/05/2019
WINNIPEG, Manitoba, May 22, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of [...]
Organovo Updates Key Clinical Development Goals; Company Reports Preliminary Fiscal Fourth-Quarter 2019 Results
22/05/2019
- Pre-Investigational New Drug (“IND”) meeting with the FDA expected to be held in calendar 2020 - Submit first IND in calendar 2021 SAN DIEGO, May 22, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“ [...]
Diversicare Announces Agreement to Transfer Operations of Ten Centers in Kentucky
22/05/2019
BRENTWOOD, Tenn., May 22, 2019 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR) today announced a pending transaction as part of its portfolio management strategy. The Company has reached an [...]
Biophytis Announces Publication of its 2018 Annual Report
22/05/2019
Files 2018 Annual Report with the AMF Provides first quarter 2019 financial statements Enters into intellectual property agreement with Stanislas Veillet PARIS and CAMBRIDGE, Mass., May 22, 2019 (GLOBE NEWSWIRE) -- [...]
Kiadis Submits Response to the European Medicines Agency's Day 180 Second List of Outstanding Issues
22/05/2019
Amsterdam, The Netherlands, May 22, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical-stage biopharmaceutical company, today announced that it has submitted [...]
Diem Enters Into Exclusive Distribution Agreement With Emerson Ecologics for Healthcare Practitioner Line
22/05/2019
ANN ARBOR, Mich., May 22, 2019 (GLOBE NEWSWIRE) -- Diem has signed an exclusive distribution agreement with Emerson Ecologics, the nation's largest distributor of integrative wellness products to healthcare [...]
Sienna Senior Living Inc. Announces Results From Annual and Special Meeting
22/05/2019
MARKHAM, Ontario, May 22, 2019 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) is pleased to announce that it has received shareholder approval in respect of all resolutions to [...]
Genetic Technologies Announces Offering of Approximately USD 1.2 Million of American Depository Shares
22/05/2019
MELBOURNE, Australia, May 22, 2019 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”), a diversified molecular diagnostics company, today announced that it has entered into a securities [...]
Amedisys to Present at the Jefferies 2019 Healthcare Conference
22/05/2019
BATON ROUGE, La., May 22, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief [...]
OSE Immunotherapeutics to Host Key Opinion Leader Meeting on Novel Treatments in Non-Small Cell Lung Cancer
22/05/2019
Meeting Scheduled for May 30, 2019 in New York City NANTES, France, May 22, 2019 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE), today announced that it will host a Key Opinion Leader ( [...]

Pages